You can buy or sell RAPT and other stocks, options, and ETFs commission-free!
Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company. It focuses on discovering, developing and commercializing oral small molecule therapies for patients in oncology and inflammatory diseases.. The company was founded in 2015 and is headquartered in South San Francisco, CA. The listed name for RAPT is RAPT Therapeutics, Inc. Common Stock.
Brian Russell Wong
South San Francisco, California
52 Week High
52 Week Low
— per share
Expected Mar 30, Pre-Market